Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GlycoSensors is a biotechnology company specializing in the development of innovative tools for glycan analysis and the detection of carbohydrate-active enzymes. Founded as a spin-off from the University of Georgia's Complex Carbohydrate Research Center, the company leverages proprietary synthetic carbohydrate chemistry to create highly specific sensors and probes. These technologies are designed for applications in disease diagnostics, particularly for cancer and infectious diseases, as well as for monitoring biopharmaceutical production processes. By providing precise insights into glycosylation patterns, GlycoSensors aims to advance the fields of glycomics and personalized medicine. The company's products enable high-throughput screening and real-time monitoring of enzyme activities that are critical to health and disease.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Glycosensors.